UNH vs BIIB
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Biogen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BIIB |
|---|---|---|
| Price | $377.83 | $228.69 |
| Market cap | $339.14B | $33.79B |
| P/E ratio | 24.3 | 40.7 |
| ROE | 14.15% | 4.58% |
| Profit margin | 3.14% | 8.32% |
| Revenue growth | 0.40% | 3.40% |
| Dividend yield | 2.46% | — |
| Beta | 0.62 | 0.17 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BIIB in plain English
- UNH is the bigger company — about 10.0× the market cap of BIIB.
- UNH is cheaper on earnings (P/E 24.3 vs 40.7).
- UNH earns a higher return on equity (14% vs 5%).
- BIIB is growing revenue faster (3% vs 0%).
- UNH pays a dividend (2.46%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BIIB return calculator
See what $1,000 in Biogen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.